{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Array Biopharma", "item": "https://www.patentleaderboard.com/company/array-biopharma"}, {"@type": "ListItem", "position": 3, "name": "D. David Hennings", "item": "https://www.patentleaderboard.com/inventor/fl:d._ln:hennings-2"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
DH

D. David Hennings — 2 Patents

ABArray Biopharma: 2 patents #203 of 335Top 65%
Boulder, CO: #2,349 of 5,018 inventorsTop 50%
Colorado: #17,188 of 40,980 inventorsTop 45%
Overall (All Time): #1,709,992 of 4,157,543Top 45%
2 Patents All Time
D. David Hennings has been granted 2 US patents while listed as an inventor at Array Biopharma. All of these patents were granted in 2014. D. David Hennings ranks #1,709,992 of 4,157,543 US inventors in our database (top 41.1%). Patent records list D. David Hennings in Boulder, CO, US.

Issued Patents All Time

Showing 1–2 of 2 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
8841455 Substituted N-(1H-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cFMS inhibitors Mark Laurence Boys, Michael Bradley, Robert Kirk DeLisle, April L. Kennedy, Fredrik P. Marmsater +7 more 2014-09-23 $3,108,000
8648087 N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases Joseph P. Lyssikatos, Julie Marie Greschuk, Fredrik P. Marmsater, Qian Zhao, Weidong Liu 2014-02-11 $7,569,000